Apyx Medical
APYX
68 hedge funds and large institutions have $183M invested in Apyx Medical in 2021 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 24 increasing their positions, 25 reducing their positions, and 3 closing their positions.
133% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 3
37% more capital invested
Capital invested by funds: $134M → $183M (+$49.6M)
6% more funds holding
Funds holding: 64 → 68 (+4)
1.2% more ownership
Funds ownership: 54.15% → 55.35% (+1.2%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
4% less repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 25
98% less call options, than puts
Call options by funds: $9K | Put options by funds: $406K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RC
Roubaix Capital
Denver,
Colorado
|
+$1.81M |
| 2 |
JP Morgan Chase
New York
|
+$1.75M |
| 3 |
EI
EAM Investors
Solana Beach,
California
|
+$1.34M |
| 4 |
BlackRock
New York
|
+$957K |
| 5 |
PVI
Pura Vida Investments
New York
|
+$557K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KAS
Kestra Advisory Services
Austin,
Texas
|
-$1.61M |
| 2 |
State Street
Boston,
Massachusetts
|
-$646K |
| 3 |
ACM
Archon Capital Management
Seattle,
Washington
|
-$527K |
| 4 |
Renaissance Technologies
New York
|
-$406K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$305K |
APYX Hedge Fund Activity: Q1 2021 in Review
68 of the 5,711 institutional investors tracked by Wall St. Rank reported a position in Apyx Medical (APYX) for Q1 2021, worth a combined $183M — up 37% from $134M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new APYX positions and 3 closed out — a net gain of 4 holders — while 24 added to existing stakes and 25 trimmed.
The largest buyer was Roubaix Capital, opening a new position worth an estimated $1.81M. The largest seller was Kestra Advisory Services, exiting entirely with an estimated $1.61M sold.
- 68 institutional investors held Apyx Medical (APYX) as of Q1 2021, up from 64 in Q4 2020.
- Funds reported $183M of Apyx Medical stock for Q1 2021, up 37% quarter-over-quarter.
- 7 funds opened new Apyx Medical positions in Q1 2021 and 3 closed out, a net change of +4 holders.
- The largest Apyx Medical buyer in Q1 2021 was Roubaix Capital, an estimated $1.81M added.
- The largest Apyx Medical seller in Q1 2021 was Kestra Advisory Services, an estimated $1.61M sold.
Based on aggregated 13F filings for Q1 2021.